🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
115.31
-4.08 (-3.42%)
At close: Nov 20, 2026, 4:00 PM EST
125.75
+10.44 (9.05%)
After-hours: Nov 20, 2026, 4:36 PM EST

Kymera Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,8446,2252,6061,4131,3693,259
Market Cap Growth
112.75%138.91%84.43%3.16%-57.98%18.59%
Enterprise Value
8,2755,3301,7831,0597912,666
Last Close Price
119.3977.8140.2325.4624.9663.49

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-34.2734.2734.2734.2734.27
PS Ratio
95.59158.7555.3517.9829.2544.75
PB Ratio
6.313.943.123.582.797.09
P/TBV Ratio
6.053.943.123.582.797.09

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
80.24135.9337.8713.4716.8836.61

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.050.110.210.040.04
Net Debt / Equity Ratio
-0.97-0.97-0.91-0.89-1.11-1.20
Net Debt / EBITDA Ratio
3.944.543.042.153.405.55
Net Debt / FCF Ratio
5.436.563.682.563.484.21
Asset Turnover
0.070.030.060.130.080.13
Quick Ratio
10.8310.197.214.595.744.78
Current Ratio
11.1310.477.534.735.884.88
Return on Equity (ROE)
-27.29%-25.78%-36.38%-33.21%-32.60%-26.96%
Return on Assets (ROA)
-24.36%-22.89%-28.81%-24.93%-25.61%-18.34%
Return on Capital Employed (ROCE)
-24.10%-20.80%-28.20%-33.80%-30.30%-19.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.14%-5.00%-8.59%-10.40%-11.30%-3.08%
FCF Yield
-2.96%-3.77%-7.96%-9.72%-11.39%-4.01%
Buyback Yield / Dilution
-17.58%-12.59%-28.58%-8.22%-12.39%-176.60%
SEC Filings: 10-K · 10-Q